Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status
- 1 July 1998
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Histopathologic findings of advanced neuroblastoma after intensive induction chemotherapyJournal of Pediatric Surgery, 1997
- Expression of multidrug resistance-related P-glycoprotein shows good prognosis in neuroblastomaJournal of Pediatric Surgery, 1997
- Genetic Clinical Markers of Human Neuroblastoma with Special Reference to N-myc Oncogene: Amplified or Not Amplified? – An OverviewTumor Biology, 1996
- Treatment combined with bone marrow transplantation for advanced neuroblastoma: An analysis of patients who were pretreated intensively with the protocol of the study group of JapanMedical and Pediatric Oncology, 1995
- What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese study group for the treatment of advanced neuroblastomaJournal of Pediatric Surgery, 1994
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for NeuroblastomaNew England Journal of Medicine, 1991
- Immunohistochemical analysis of N-myc protein expression in neuroblastoma: Correlation with prognosis of patientsJournal of Pediatric Surgery, 1991
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984